Litmore Capital

investment firm

Litmore Capital

Number of Investments

Number of Lead Investments

Litmore Capital has made 2 investments. Their most recent investment was on Feb 21, 2017, when Bristol Myers Squibb raised $80M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Feb 21, 2017 Bristol Myers Squibb	Post-IPO Equity	$80M	Biotechnology	—
Nov 1, 2016 Biohaven Pharmaceutical	Series Unknown	$80M	Biotechnology	—

Litmore Capital has had 2 exits. Litmore Capital most notable exits include Biohaven Pharmaceutical , Bristol Myers Squibb

Date	Company Name	Exit Type	Industry
May 5, 2017	Biohaven Pharmaceutical	M&A	Biotechnology	Detail
Jan 1, 1972	Bristol Myers Squibb	IPO	Biotechnology	Detail